Overview

Evaluating the Safety and Efficacy of Euiiyin-tang on Obesity

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this study is obese patient with Euiiyin-tang for 12 weeks will show a superior reduction compared to those taking the placebo.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Kyunghee University Medical Center
Collaborators:
Gachon University Gil Medical Center
Korea Health Industry Development Institute